3+ hour, 34+ min ago  (422+ words) Experimental radiation therapy aims to treat pediatric malignant gliomas Written by Marisa Wexler, MS | April 9, 2026 The U. S. Food and Drug Administration (FDA) has awarded orphan drug designation to the experimental radiation therapy rhenium Re186 obisbemeda " slated to be marketed under the brand…...

1+ day, 3+ hour ago  (680+ words) Noninvasive test called a 'breakthrough' in gynecologic cancer diagnosis Written by Marisa Wexler, MS | April 8, 2026 A test that uses artificial intelligence (AI) to analyze genetic data from a vaginal swab can detect endometrial cancer with high diagnostic accuracy, a new…...

2+ day, 3+ hour ago  (599+ words) Phase 2 DOMMINO-1 study tests therapy in patients with hard-to-treat disease Written by Michela Luciano, Ph D | April 7, 2026 The first patient has been dosed in a Phase 2 trial testing an all-oral, triple-combination treatment that includes Cellcentric's investigational therapy inobrodib in people…...

3+ day, 3+ hour ago  (160+ words) Written by Marisa Wexler, MS | April 6, 2026 Caris Life Sciences has developed a genetic test that aims to simplify care for people with a group of blood cancers known as myeloid malignancies. "This launch reflects our commitment to delivering a single,…...

9+ mon, 6+ day ago  (278+ words) Treatment, now preclinical, aims to kill cancer cells by going after their DNA Written by Marisa Wexler, MS | July 3, 2025 The U. S. Food and Drug Administration (FDA) has granted orphan drug designation to GLIX1, a cancer treatment now in the preclinical stages of…...

8+ mon, 2+ day ago  (502+ words) Therapy was granted orphan drug status by FDA, EMA Written by Steve Bryson, Ph D | Aug. 7, 2025 The U. S. Food and Drug Administration (FDA) will allow Hemispherian to test its first-in-class experimental therapy for glioblastoma in a Phase 1 clinical trial. The first-in-human…...

7+ mon, 5+ day ago  (476+ words) Altering key molecule in extracellular matrix can prevent cancer spread: Study Written by Marisa Wexler, MS | Sept. 4, 2025 Researchers may have found a way to halt the spread of aggressive brain tumors by targeting the environment around the cancer cells. A…...

1+ week, 1+ hour ago  (436+ words) Phase 1/2a study evaluating safety, efficacy in patients with recurrent disease Written by Andrea Lobo | April 2, 2026 GLIX1, a treatment for recurrent and progressive glioblastoma and other high-grade gliomas, has begun human testing in a Phase 1/2a clinical trial, said Bio Line Rx, which…...

1+ week, 1+ hour ago  (431+ words) I'm no longer just her son, and she's not merely my mum Written by Samuel Ike | April 2, 2026 Recently, I've observed a new type of quietness between my mum and me. It is not the usual silence that arises after a…...

6+ day, 3+ hour ago  (179+ words) Trial data show TTFields as part of combo regimen may halt disease progression Written by Marisa Wexler, MS | April 3, 2026 A type of electrical therapy called Tumor Treating Fields (TTFields), given in combination with chemotherapy and other medication, may help prevent…...